Syndax Pharmaceuticals Cash from Investing (TTM) Trends

Syndax Pharmaceuticals Inc (SNDX)

20.79 -0.18 (-0.86%) USD | NASDAQ | Apr 24, 16:00

20.82 +0.02 (+0.12%) Pre-Market: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	117.61M
September 30, 2023	-3.73M
June 30, 2023	-50.60M
March 31, 2023	-174.46M
December 31, 2022	-186.19M
September 30, 2022	-108.52M
June 30, 2022	-75.09M
March 31, 2022	-3.463M
December 31, 2021	-40.87M
September 30, 2021	-45.06M
June 30, 2021	-52.41M
March 31, 2021	-152.70M
December 31, 2020	-142.53M
September 30, 2020	-71.79M
June 30, 2020	-78.70M
March 31, 2020	-19.02M
December 31, 2019	12.78M
September 30, 2019	22.15M
June 30, 2019	13.29M
March 31, 2019	51.51M
December 31, 2018	51.40M

Date	Value
September 30, 2018	36.99M
June 30, 2018	40.40M
March 31, 2018	-15.44M
December 31, 2017	-17.07M
September 30, 2017	2.806M
June 30, 2017	3.936M
March 31, 2017	39.87M
December 31, 2016	-18.28M
September 30, 2016	-57.27M
June 30, 2016	-72.73M
March 31, 2016	-89.32M
December 31, 2015	-61.67M
September 30, 2015	-46.21M
June 30, 2015	-38.80M
March 31, 2015	-19.05M
December 31, 2014	1.888M
September 30, 2014	-0.064M
June 30, 2014	-0.072M
March 31, 2014	-2.575M
December 31, 2013	-4.027M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-186.19M

Minimum

Dec 2022

117.61M

Maximum

Dec 2023

-54.70M

Average

-50.60M

Median

Jun 2023

Cash from Investing (TTM) Benchmarks